Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C Maki

Showing results (11-20 of 246) with videos related to

Pageof 25
Sort By:
Journal of Clinical Lipidology|September 29, 2024
NLA Expert Clinical Consensus on apolipoprotein B recommends expanded clinical use and improved patient accessKevin C Maki, P Barton Duell
Journal of Clinical Lipidology|April 18, 2025
Oral semaglutide and reduction in major adverse cardiovascular eventsP Barton Duell, Kevin C Maki
Journal of Clinical Lipidology|March 21, 2026
From the Editors: Dietary Guidelines for Americans, an update on statin safety, and an upcoming meta-analysis of MACE reduction in primary prevention CVOTsKevin C Maki, P Barton Duell
Journal of Clinical Lipidology|March 13, 2025
Helping clinicians interpret the evidence supporting dietary recommendationsKevin C Maki, P Barton Duell
Journal of Clinical Lipidology|December 14, 2024
From the editors: Upcoming treatments for familial chylomicronemia syndrome: Agents that inhibit production of apolipoprotein CIIIP Barton Duell, Kevin C Maki
Current Atherosclerosis Reports|July 10, 2023
An Update on Nutrition Guidance for Cardiovascular HealthLiana L Guarneiri, Kevin C Maki
Current Opinion in Clinical Nutrition and Metabolic Care|December 15, 2018
Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentratesKevin C Maki, Mary R Dicklin
Journal of the American College of Cardiology|January 4, 2023
Caution Against Rejecting All Dietary Supplements for LDL Cholesterol ReductionKevin C Maki, Mary R Dicklin
Current Opinion in Lipidology|April 26, 2017
Do triglyceride-lowering drugs decrease risk of cardiovascular disease?Kevin C Maki, Mary R Dicklin
Nutrients|July 6, 2018
Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?Kevin C Maki, Mary R Dicklin
Pageof 25

Showing results (11-20 of 246) with videos related to

Sort By:
Pageof 25
Journal of Clinical Lipidology|September 29, 2024
NLA Expert Clinical Consensus on apolipoprotein B recommends expanded clinical use and improved patient accessKevin C Maki, P Barton Duell
Journal of Clinical Lipidology|April 18, 2025
Oral semaglutide and reduction in major adverse cardiovascular eventsP Barton Duell, Kevin C Maki
Journal of Clinical Lipidology|March 21, 2026
From the Editors: Dietary Guidelines for Americans, an update on statin safety, and an upcoming meta-analysis of MACE reduction in primary prevention CVOTsKevin C Maki, P Barton Duell
Journal of Clinical Lipidology|March 13, 2025
Helping clinicians interpret the evidence supporting dietary recommendationsKevin C Maki, P Barton Duell
Journal of Clinical Lipidology|December 14, 2024
From the editors: Upcoming treatments for familial chylomicronemia syndrome: Agents that inhibit production of apolipoprotein CIIIP Barton Duell, Kevin C Maki
Current Atherosclerosis Reports|July 10, 2023
An Update on Nutrition Guidance for Cardiovascular HealthLiana L Guarneiri, Kevin C Maki
Current Opinion in Clinical Nutrition and Metabolic Care|December 15, 2018
Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentratesKevin C Maki, Mary R Dicklin
Journal of the American College of Cardiology|January 4, 2023
Caution Against Rejecting All Dietary Supplements for LDL Cholesterol ReductionKevin C Maki, Mary R Dicklin
Current Opinion in Lipidology|April 26, 2017
Do triglyceride-lowering drugs decrease risk of cardiovascular disease?Kevin C Maki, Mary R Dicklin
Nutrients|July 6, 2018
Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?Kevin C Maki, Mary R Dicklin
Pageof 25